Notes
International Severe Acute Respiratory and Emerging Infection Consortium-Clinical Characterisation Protocol-United Kingdom
References
1. Drake TM, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology : 7 May 2021. Available from: URL: https://doi.org/10.1016/S2665-9913(21)00104-1
2. Kragholm K, et al. Non-steroidal anti-inflammatory drug use in COVID-19. The Lancet Rheumatology : 7 May 2021. Available from: URL: https://doi.org/10.1016/S2665-9913(21)00144-2
Rights and permissions
About this article
Cite this article
Do NSAIDs increase the severity of COVID-19?. Reactions Weekly 1856, 7 (2021). https://doi.org/10.1007/s40278-021-96000-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-96000-7